R
Roser Solans-Laqué
Researcher at Autonomous University of Barcelona
Publications - 85
Citations - 2027
Roser Solans-Laqué is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Medicine & Giant cell arteritis. The author has an hindex of 22, co-authored 71 publications receiving 1739 citations. Previous affiliations of Roser Solans-Laqué include Hebron University.
Papers
More filters
Journal ArticleDOI
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
Raphaèle Seror,Elke Theander,Johan G. Brun,Manel Ramos-Casals,Valeria Valim,Thomas Dörner,Hendrika Bootsma,Athanasios G. Tzioufas,Roser Solans-Laqué,Thomas Mandl,Jacques-Eric Gottenberg,Eric Hachulla,Kathy L. Sivils,Wan-Fai Ng,Anne Laure Fauchais,Stefano Bombardieri,Guido Valesini,Elena Bartoloni,Alain Saraux,Matija Tomšič,Takayuki Sumida,Susumu Nishiyama,Roberto Caporali,Aike A. Kruize,C. Vollenweider,Philippe Ravaud,Claudio Vitali,Xavier Mariette,Simon J Bowman +28 more
TL;DR: The European League Against Rheumatism (EULAR) SS Patient Reported Index (ESSPRI) and the EULAR SS Disease Activity Index (ESSDAI) were validated in a prospective international 6-month duration validation study as mentioned in this paper.
Journal ArticleDOI
Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Roser Solans-Laqué,Andres Lopez-Hernandez,Bosch-Gil Ja,Andrés Palacios,Mercedes Campillo,Miquel Vilardell-Tarrés +5 more
TL;DR: Patients with primary Sjögren's syndrome have a 16-fold increased risk of developing lymphoma, and this risk increases with time, and Hypocomplementemia and lymphocytopenia at pSS diagnosis are the strongest predictors.
Journal Article
Paraneoplastic Vasculitis in Patients with Solid Tumors : Report of 15 Cases
Roser Solans-Laqué,Bosch-Gil Ja,Carmen Pérez-Bocanegra,Albert Selva-O'Callaghan,Carmen Pilar Simeón-Aznar,Miquel Vilardell-Tarrés +5 more
TL;DR: In the authors' patients, resolution of vasculitis following effective treatment of the putatively linked malignancy, and recurrence of Vasculitis heralding tumor recurrence or progression, provide strong evidence for vasculationitis being a true paraneoplastic syndrome.
Journal ArticleDOI
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
TL;DR: The data suggest that subglottic stenosis often occurs or progresses independently of other features of active WG, and that ILCD may be a safe alternative to conventional immunosuppressive therapy in patients who develop SGS in the absence of other feature of active disease, allowing reducing the treatment-related toxicity.
Journal ArticleDOI
Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.
Albert Selva-O'Callaghan,Moises Labrador-Horrillo,X. Muñoz‐Gall,Xavier Martínez-Gómez,J Majó-Masferrer,Roser Solans-Laqué,Carmen Pilar Simeón-Aznar,F Morell-Brotard,Miquel Vilardell-Tarrés +8 more
TL;DR: It was concluded that clinical and immunological characteristics allowed the grouping of patients into different types of PM/DM lung-associated disease, and the presence of ASA did not affect survival.